Arkolith/Insider Trading/GEMP/Form 4

Sassine Andy

DirectorGemphire Therapeutics Inc. (GEMP) · full profile →Form 4 · filed Mar 14, 2017
Net Buying
Open-Market Buys
$200K
Open-Market Sells
$0
Net Open-Market Flow
$200K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2017Buy(P)21K$9.47$200K136K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2017Buy(P)16K$9.47$150K16K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001596771-17-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Gemphire Therapeutics Inc.

Build

Ask your agent about GEMP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001596771-17-000023"
Ask your agent
Use Arkolith to summarize insider buying and selling at Gemphire Therapeutics Inc.
over the last 90 days and cite the filings.